Somnics Health Launches iNAP Essentials

Somnics Health has launched iNAP Essentials, a program giving patients access to iNAP Sleep Therapy at an affordable monthly rate. This new initiative removes cost barriers to treatment and expands patients’ ability to obtain comfortable, mask-free Obstructive Sleep Apnea (OSA) therapy.

More than 50 million Americans suffer from OSA, yet 80% remain untreated, and many who start CPAP therapy abandon it due to discomfort. “The OSA treatment landscape is no longer CPAP-only. iNAP is effective, comfortable, and discreet—and now, more affordable than ever,” Somnics Health General Manager Olivier Lauzeral said. “With iNAP Essentials, we’re removing the affordability hurdle.”

iNAP is a U.S. Food and Drug Administration-cleared, clinically validated therapy that uses gentle negative pressure to keep the airway open during sleep without forcing air through a mask. It works by creating a light vacuum in the oral cavity, shifting soft tissues forward and preventing obstruction.

iNAP does not use a mask or forced air and makes no noise. The compact and travel-friendly system uses a rechargeable battery that lasts up to five nights, and provides patients both the freedom and discretion that is lacking in other OSA solutions.

“Adherence is one of iNAP’s biggest strengths,” Lauzeral added. “When therapy fits into your life instead of disrupting it, patients stay with it—and that’s how we win against OSA.”

For a $58 monthly charge (for two years), iNAP Essentials includes:

• A full iNAP Starter Kit
• Three months of supplies (mouthpiece, tubing)
• Free nationwide shipping
• Personalized onboarding with a trained iNAP Sleep Coach
• Access to the iNAP Sleep App for tracking progress and sharing data with providers

While CPAP has long dominated the OSA space, patient dissatisfaction is driving demand for alternatives like oral appliances, positional therapy, and implantable devices. Many of these, however, are costly, invasive, or hard to access.

iNAP, on the other hand, is non-invasive, portable, and now financially accessible. Clinical studies show iNAP can significantly reduce AHI, with outcomes on par with CPAP—but with higher comfort and adherence.

For patients who prefer to own their device upfront, Somnics has partnered with Affirm to offer interest-free installment plans. “Some patients want to purchase the device outright. With Affirm, they can do that without financial strain,” Lauzeral said.

iNAP is available by prescription only, ensuring medical oversight from a sleep specialist. Adoption is growing across VA hospitals, sleep centers, and DME providers.

“Physicians are seeing the value of iNAP in improving adherence and patient satisfaction,” Lauzeral emphasized. “When patients feel empowered, they stay engaged—and that’s the future of sleep medicine.”

Untreated sleep apnea increases the risk of heart disease, stroke, diabetes, and cognitive decline.

Somnics Health is a medical device company focused on advancing patient-centric solutions for sleep-disordered breathing. Its flagship product, iNAP Sleep Therapy, helps patients treat OSA without the discomfort of traditional therapies. Its offices are located in California and Taiwan.